Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 235-244

  Goulden, Nicholas J ^a,b   Knechtli, Christopher J C ^a,b   Garland, Russell J ^a   Langlands, Kenneth ^a   Hancock, Jeremy P ^a   Potter, Michael N ^a,b   Steward, Colin G ^a,b   Oakhill, Anthony ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Acute lymphoblastic leukaemia; Immunoglobulin heavy chain gene; Minimal residual disease; Risk factor; T cell receptor gene

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IMMUNOGLOBULIN HEAVY CHAIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CHILD; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FORECASTING; GENE REARRANGEMENT; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0031982515     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00574.x     Document Type: Article

References (28)

1. Beishuizen, A., Verhoeven, M.A., Hahlen, K., van Wering, E.R. & van Dongen, J.J. (1993) Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leukemia at diagnosis. Leukemia, 7, 60-63.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. British Journal of Haematology, 33, 451-458.
3. Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Seshadri, R., Toogood, L. Waters, K., Tauro, G., Ekert, H. & Morley, A.A. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196-200.
4. Campana, D., Coustan-Smith, E. & Janossy, G. (1990) Immunophenotyping in haematological diagnosis. Baillieres Clinical Haematology, 3, 889-919.
5. Cavé, H., Guidal, C., Rohrlich, P., Delfau, M.H., Broyart, A., Lescoeur, B., Rahimy, C., Fenneteau, O., Monplaisir, N., d'Auriol, L. Elion, J., Vilmer, E. & Grandchamp, B. (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood, 83, 1892-1902.
6. Chessells, J.M., Bailey, C. & Richards. S.M. (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet, 345, 143-148.
7. Evans, P.A.S., Short, M.A., Owen, R.G., Mistry, D., Shiach, C.R., Kinsey, S., Davies, F.E., Jack, A.S. & Morgan, G.J. (1997) A clinical evaluation of fluorescent consensus immunoglobulin heavy chain PCR for the monitoring of residual disease in paediatric acute lymphoblastic leukaemia. (Abstract). British Journal of Haematoloyg, 97, 11.
8. Goulden, N., Langlands, K., Steward, C., Katz, F., Potter, M., Chessells, J. & Oakhill, A. (1994) PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. British Journal of Haematology, 87, 282-285.
9. Knechtli, C.J.C., Goulden, N.J., Langlands, K. & Potter, M.N. (1995) The study of minimal residual disease in acute lymphoblastic leukaemia. Journal of Clinicl Pathology: Clinical Molecular Pathology, 48, M65-M73.
10. Kwok, S. & Higuchi, R. (1989) Avoiding false positives with PCR. Nature, 339, 237-238.
11. Langlands, K., Goulden, N.J., Steward, C.G., Potter, M.N., Cornish, J.M., Pamphilon, D.H. & Oakhill, A. (1994) False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia. Blood, 84, 1352-1353.
12. Langlands, K., Goulden, N.J., Steward, C.G., Potter, M.N. & Oakhill, A. (1995) Solid-phase sequencing of multiple PCR products resolved by polyacrylamide gel electrophoresis. Biotechniques, 18, 618-620.
13. Lilleyman, J.S., Gibson, B.E.S., Stevens, R.F., Will, A.M., Hann, I.M., Richard, P., Richards, S.M. & Hill, F.G.H. (1997) Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia; clinical importance and the effect of daunorubicin. British Journal of Haematology, 97, 603-606.
14. Martens, A.C.M., Schultz, F.W. & Hagenbeek, A. (1987) Non-homogeneous distribution of leukemia in the bone marrow during minimal residual disease. Blood, 70, 1073-1076.
15. Neale, G.A.M., Pui, C.H., Mahmoud, H.H., Mirro, J., Jr, Crist, W.M., Rivera, G.K. & Goorha, R.M. (1994) Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extramedullary relapse of T-cell acute lymphoblastic leukemia. Leukemia, 8, 768-775.
16. O'Reilly, J., Meyer, B., Baker, D., Herrmann, R., Cannell, P. & Davies, J. (1995) Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukemia. Leukemia, 9, 624-627.
17. Ouspenskaia, M.V. Johnston, D.A., Roberts, W.M., Estrov, Z. & Zipf, T.F. (1995) Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia, 9, 321-328.
18. Owen, R.G., Goulden, N.J., Oakhill, A., Shiach, C., Evans, P.A., Potter, M.N. & Morgan, G.J. (1997) Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL. British Journal of Haematology, 97, 457-459.
19. Potter, M.N., Steward, C.G. & Oakhill, A. (1993) The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 83, 412-418.
20. Pui, C.H. (1995) Childhood leukemias. New England Journal of Medicine, 332, 1618-1627.
21. Roberts, W.M., Estrov, Z., Kitchingman, G.R. & Zipf, T.F. (1996) The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences. Leukemia and Lymphoma, 20, 181-197.
22. Roberts, W.M., Estrov, Z., Ouspenskaia, M.V., Johnston, D.A., McClain, K.L. & Zipf, T.F. (1997) Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New England Journal of Medicine, 336, 317-323.
23. Sambrook, J., Fritsch, K.F. & Maniatis, T. (1989) Commonly used techniques in molecular cloning. Molecular Cloning: a Laboratory Manual, 2nd edn, appendix E, page E. 3. Cold Spring Harbor Laboratory Press, New York.
24. Seriu, T., Dieter-Ludwig, W., Schrappe, M., Erz. D., Stark, Y. & Bartram, C.R. (1997) Prospective monitoring of minimal residual disease in childhood acute lymphoblastic leukemia enrolled in German BFM study. (Abstract). Annals of Hemtology, 74. (Suppl. I). A53.
25. Steenbergen, E.J., Verhagen, O.J., van Leeuwen, E.F., van den Berg, H., Behrendt, H., Slater, R.M., von dem Borne, A.E. & van der Schoot, C.E. (1995) Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or lirst relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia, Leukemia, 9, 1726-1734.
26. Steenbergen, E.J., Verhagen, O.J., van Leeuwen, E.F., von dem Borne, A.E. & van der Schoot, C.E. (1993) Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia, Blood, 82, 581-589.
27. Steinherz, P.G., Gaynon, P.S., Breneman, J.C., Cherlow, J.M., Grossman, N.J., Kersey, J.H., Johnstone, H.S., Sather, H.N., Trigg, M.E., Chappell, R., Hammond, D. & Bleyer W.A., (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia: the importance of early marrow response: report from the Childrens Cancer Group. Journal of Clinical Oncology, 14, 389-398.
28. Steward, C.G., Goulden, N.J., Katz, F., Baines, D., Martin, P.G., Langlands, K., Potter, M.N., Chessells, J.M. & Oakhill, A. (1994) A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood, 83, 1355-1362.